Abstract

Thesis

Short term effect of Intravenous Intermittent Iron Infusion versus Bolus Iron Infusion on Iron parameters in Hemodialysis patients

Iman Ibrahim Sarhan, Hussein Sayed Hussein, Islam Omar Elshazly* and Mahmoud Salah Hassan

Published: 21 December, 2017 | Volume 1 - Issue 1 | Pages: 055-059

Intravenous iron is used in combination with erythropoi esis-stimulating agents to treat the anemia of hemodialysis patients, however, there is variety in the dose and the frequency. So we compare bolus intravenous iron administration protocol vs an intermittent intravenous iron infusion protocol for 3 months in a single blinded design that was conducted on 30 patients randomized into 2 matching groups. Iron parameter, hemoglobin level, and CRP were monitored before and at the end of study. Patients with end stage renal disease on regular hemodialysis with iron deficiency anemia can be treated with intravenous iron administration either by the protocol of divided doses of IV iron through the sessions of hemodialysis or by giving the total dose of iron needed as a single large dose on only one session of hemodialysis, obtaining the same outcome in correction of iron parameters in treatment of iron deficiency anemia.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001008 Cite this Article Read Full Article PDF

References

  1. Collins AJ, Li S, St Peter W, Ebben J, Roberts T, et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol. 2001; 12: 2465-2473. Ref.: https://goo.gl/pc8Ad7
  2. Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol. 2010; 6: 699-710. Ref.: https://goo.gl/BnBSEf
  3. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009; 19: 2019-2032. Ref.: https://goo.gl/S8UVDm
  4. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355: 2085-2098. Ref.: https://goo.gl/CV2DWR
  5. Robinson BM, Fuller DS, Bieber BA, Turenne MN, Pisoni RL. The DOPPS Practice Monitor for US dialysis care: Trends through April 2011. Am J Kidney Dis. 2012; 59: 309-312. Ref.: https://goo.gl/142wo9
  6. Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA. Changing patterns of anemia management in US hemodialysis patients. Am J Med. 2012; 125: 906-914. Ref.: https://goo.gl/9WXsR4
  7. Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, et al. Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol. 2015; 26: 1238-1247. Ref.: https://goo.gl/LTNZrC
  8. Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, et al. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol. 2015; 41: 354-361. Ref.: https://goo.gl/s6RmSQ
  9. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007; 18: 975-984. Ref.: https://goo.gl/E4TEKS
  10. Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, et al. The comparative short-term effectiveness of iron dosing and formulations in U.S. hemodialysis patients. Am J Med. 2013; 126: 541. Ref.: https://goo.gl/yzkkeu
  11. Thakuria M, Ofsthun NJ, Mullon C, Diaz-Buxo JA. Anemia management in patients receiving chronic hemodialysis. Semin Dial. 2011; 24: 597-602. Ref.: https://goo.gl/65Yj7u
  12. Yong K, Kairaitis L. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort. Nephrology (Carlton). 2010; 15: 288-293. Ref.: https://goo.gl/gzARxH
  13. Besarab A. Anemia and iron management. Semin Dial. 2011; 24: 498-503. Ref.: https://goo.gl/efEXmw
  14. Macdougall IC, Tucker B, Thompson J, Tomson CRV, Baker LR, et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int. 1996; 50: 1694-1699. Ref.: https://goo.gl/7JPnK9
  15. Locatelli F, Aligama P, Barany P, Canaud B, Carrera F, et al. European Best Practice Guidelines Working Group. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant. 2004; 19: 1-47. Ref.: https://goo.gl/Q9aeBu
  16. Fenwick S, Peebles G. Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. Journal of Renal Care. 2011; 37: 47-51. Ref.: https://goo.gl/fUjn9R
  17. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007; 18: 975-984. Ref.: https://goo.gl/JwhQM9
  18. Kapoian T, O’Mara NB, Singh AK, Moran J, Rizkala AR, et al. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol. 2008; 19: 372-379. Ref.: https://goo.gl/Z2upWz
  19. Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol. 2004; 15: 1623-1632. Ref.: https://goo.gl/9Tc7zt
  20. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16: 3070-3080. Ref.: https://goo.gl/KxPzSd
  21. Abhijit VK, Janet KF, Alan RE, Lily W, Wolfgang CW, et al. Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients. PLOS ONE. 2013. Ref.: https://goo.gl/NsBWDH

Similar Articles

Recently Viewed

  • Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review
    Elena Popa*, Raluca Ioana Avram, Andrei Emilian Popa and Adorata Elena Coman Elena Popa*, Raluca Ioana Avram, Andrei Emilian Popa, Adorata Elena Coman. Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review. Arch Surg Clin Res. 2024: doi: 10.29328/journal.ascr.1001081; 8: 032-038
  • Imaging aspect of neuromyelitis optica: a case report and review of the literature
    H Lhajoui*, I Bounnit, N Moussali, A Merzem, O Amriss, H Belgadir and N Elbenna H Lhajoui*,I Bounnit,N Moussali,A Merzem,O Amriss,H Belgadir,N Elbenna. Imaging aspect of neuromyelitis optica: a case report and review of the literature. Arch Case Rep. 2021: doi: 10.29328/journal.acr.1001055; 5: 036-038
  • Renal denervation for resistant hypertension and heart failure with a reduced ejection fraction
    Carles Cañameras Fugasot, Oriol Rodríguez-Leor, Josep Riera Sadurní, Edgar Fadeuilhe, Javier Paul Martínez, Marina Urrutia Jou, Jordi Bover and Maribel Troya-Saborido* Carles Cañameras Fugasot,Oriol Rodríguez-Leor,Josep Riera Sadurní,Edgar Fadeuilhe,Javier Paul Martínez,Marina Urrutia Jou,Jordi Bover,Maribel Troya-Saborido*. Renal denervation for resistant hypertension and heart failure with a reduced ejection fraction. Ann Clin Hypertens. 2023: doi: 10.29328/journal.ach.1001033; 7: 001-003
  • Transformative Convergence: Exploring the Nexus of Engineering, Science and Technology in Intensive Care
    Ever Leonardo Rojas-Díaz* Ever Leonardo Rojas-Díaz*. Transformative Convergence: Exploring the Nexus of Engineering, Science and Technology in Intensive Care. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001095; 8: 056-057
  • A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient
    Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg and Khelif Abderrahim Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg, Khelif Abderrahim. A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001025; 7: 025-028

Read More

Most Viewed

Read More

Help ?